Use Babyguard® Breast Milk Probiotics to Verify the Authenticity of the Gut-Breast Axis Hypothesis
1 other identifier
interventional
30
1 country
1
Brief Summary
In order to understand the life history of the breast milk flora, explore its composition, source of strains, and ability to colonize the baby's intestinal environment, to find out strains with the potential of probiotics in breast milk
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 10, 2020
CompletedFirst Posted
Study publicly available on registry
December 17, 2020
CompletedStudy Start
First participant enrolled
November 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2024
CompletedJanuary 10, 2025
January 1, 2025
2.9 years
December 10, 2020
January 8, 2025
Conditions
Outcome Measures
Primary Outcomes (6)
Microflora of mother's feces
Collect mother's feces for bacterial analysis.The mother's feces use Qiagen stool mini kit to extract DNA, and then use the intestinal bacteria primers to detect the presence of intestinal bacteria in the feces.
4-6 weeks after the baby is born
Group. B Streptococcus (GBS) screening
Use sterile cotton sticks for vaginal samples, and then perform Group. B Streptococcus (GBS) screening
35-37 weeks of pregnancy
The microflora of maternal blood
Use venous blood to collect 20 ml of mother's blood for bacterial analysis.The mother's blood uses Qiagen DNA isolation mini kit to extract DNA, and then uses intestinal bacteria primers to detect the presence of intestinal bacteria in the blood
4-6 weeks after the baby is born
Metabolic analysis of maternal urine
Collect 10 ml of mother's urine for intestinal dysbiosis analysis. Use Qiagen DNA isolation mini kit to extract DNA from the mother's urine, and then use the intestinal bacteria primer to detect the presence of intestinal bacteria in the urine.
4-6 weeks after the baby is born
Bacteria analysis of breast milk
Collect 10 ml of breast milk for bacterial phase analysis.Use Qiagen DNA isolation mini kit to extract DNA from breast milk, and then use intestinal bacteria primers to detect whether the breast milk contains intestinal bacteria.
4-6 weeks after the baby is born
Bacteria analysis of infant feces
Collect baby feces for bacterial phase analysis.Use Baby feces use Qiagen stool mini kit to extract DNA, and then use intestinal bacteria primers to detect the presence of intestinal bacteria in the feces.
4-6 weeks after the baby is born
Study Arms (2)
Placebo
PLACEBO COMPARATORconsume 1 sachet per day for 1 months
Babyguard® Breast Milk Probiotics
EXPERIMENTALconsume 1 sachet per day for 1 months
Interventions
consume 1 sachet per day for 1 months
Eligibility Criteria
You may qualify if:
- At least 20 years old, pregnant women with non-high-risk pregnancy risk assessed by obstetricians and gynecologists, healthy mothers and infants with no abnormal obstetric examination results
You may not qualify if:
- Pregnant women who have used oral or injectable antibiotics within three months before delivery, or women who need a cesarean section for any reason during pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- TCI Co., Ltd.lead
Study Sites (1)
National Taiwan University Hospital
Taipei, Zhongzheng District, 100225, Taiwan
Study Officials
- PRINCIPAL INVESTIGATOR
Ming Shiang Wu, Doctor
National Taiwan University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 10, 2020
First Posted
December 17, 2020
Study Start
November 1, 2021
Primary Completion
September 30, 2024
Study Completion
November 30, 2024
Last Updated
January 10, 2025
Record last verified: 2025-01